Different types of integration of EML4 with ALK or other genes (133), the presence of a secondary mutation in ALK, and activation of alternative signaling pathways such as EGFR, are the mechanisms by which tumor cells become resistant (139). This evidence concerns the gene EML4 and neoplasm.